10 Aug 2022 Other

Leukaemia UK unveils an exciting new brand 

Leukaemia UK has today revealed a bold new look and feel that embodies the charity’s ambitious new strategy and our desire to be a greater force for change. 

Bringing together the leukaemia community, we want to accelerate the life-changing power of research. As a result of our new strategy, we’ve developed a new look and new messaging to help us stand out more and to get across how we’ll be going further than ever to stop leukaemia devastating lives. 

Curious

Our new brand encompasses our desire to explore new possibilities, restless for progress that will help save and improve more lives by accelerating progress in diagnosis, treatment and care. 

Through our new brand and strategy, we want to bring people together, galvanising and inspiring them to change the future, and focussing on what matters most to those impacted by leukaemia, through research, awareness and advocacy.

Collaborative

Along with our new much more user-friendly and accessible website, you will notice our new brand colours have changed to incorporate orange – the international colour of leukaemia. You might also notice that we still have some red showing in the orange gradient used across much of our brand, as Leukaemia UK is still deeply rooted within the blood cancer community and our collaborative approach runs through all our work. 

Bold

Our new logo features the handwritten word leukaemia and a double underline under the word UK, which sits to the top right – like the mathematical symbol for squared. This new logo brings together the charity’s three values: curious, collaborative and bold. It represents our focus on science and, by using a handwritten font, on the people behind the science, and the people whom that science is there to help.  

You’ll also see that some of our new style involves handwritten-style doodles, like underlining or ringing around important words, symbolising the thought process that goes into those eureka moments. 

Our imagery is bolder as we celebrate the science, making it interesting, engaging and accessible to all. We want to spark people’s imagination by focusing on our search for answers. 

 

Together with our supporters, researchers, patients and scientific and healthcare professionals across the blood cancer community, we are excited to take this next step forward. We hope you like it!

 

You can learn more about our new strategy here. 

Related posts

Less than 1% of Brits can identify all the most common symptoms of one of the deadliest types of cancer

4 September 2023

Less than 1% of Brits can identify all the most common symptoms of one of the deadliest types of cancer

New research launched today by Leukaemia Care and Leukaemia UK reveals that less than 1% (0.4%) of UK adults can accurately identify the four most common symptoms of leukaemia –…

UK’s top chefs unite at gastronomic spectacular to raise funds for life-saving leukaemia research

5 July 2023

UK’s top chefs unite at gastronomic spectacular to raise funds for life-saving leukaemia research

Twenty of the most accomplished and innovative chefs from the UK food scene will gather at The Dorchester on Monday 18th September 2023 for ‘Who’s Cooking Dinner?’, a one-of-a-kind night…

Leading leukaemia charities call on Rishi Sunak not to cut financial lifeline for blood cancer patients

24 September 2021

Leading leukaemia charities call on Rishi Sunak not to cut financial lifeline for blood cancer patients

Leukaemia Care, Leukaemia UK and Leukaemia and Lymphoma Northern Ireland, have written to the Chancellor urging him to realise the devastating impact the end of the Coronavirus Job Retention Scheme will have on the clinically extremely vulnerable (CEV).

Widespread coverage of new leukaemia therapy shows promise in first trial patient

12 December 2022

Widespread coverage of new leukaemia therapy shows promise in first trial patient

As you may have seen in the news over the weekend, a clinical trial investigating a new leukaemia treatment has shown promising results. As part of the trial, funded by…